Artikel
The Epidemiology of Invasive Aspergillosis and Resistance Patterns of Aspergillus spp. in Germany – Interim Analysis of a Multicenter Observational Study
Suche in Medline nach
Autoren
Veröffentlicht: | 19. Mai 2014 |
---|
Gliederung
Text
Introduction: Reports on increasing identification of azole-resistant Aspergillus fumigatus in clinical and environmental isolates have raised concerns with respect to the frequency and clinical relevance of resistant Aspergillus spp. in hematological high-risk patient populations.
Methods: In an observational multicenter study supported by the Deutsche José Carreras Leukämie-Stiftung e.V., the incidence of probable and proven aspergillosis according to EORTC/MSG criteria was assessed for all inpatients with acute leukemia (AML and ALL) treated at the participating hematology departments. All identified cases were documented into a web-based database (clinicalsurveys.net). Information on risk factors, site of infection, symptoms, diagnosis, treatment and outcome were documented. In addition, all participating centers completed a survey on factors that may influence the incidence of invasive aspergillosis, including use of antifungal prophylaxis, availability of diagnostic measures and use of HEPA filtration. If available, the corresponding clinical isolates were sent to a central microbiology laboratory for resistance testing and if applicable, identification of resistance mechanisms.
Results: 17 centers contributed data to the study for the period of September 2011 – December 2012. 750 patients with AML were observed over a total of 1780 hospitalizations and 44,480 patient days. 189 patients with ALL were observed over a total of 630 hospitalizations and 12,848 patient days. In these populations, 46 (6.1%) and 13 (6.9%) cases of invasive aspergillosis were identified, respectively. The local incidence rates varied considerably between 0 and 10.6%. In 30 cases (50.8%) an antifungal prophylaxis had been administered. Liposomal amphotericin B was the most frequently used agent for targeted treatment (n=24; 40.7%). 64.5% achieved a favorable response to treatment and 9% had died at day 30. One case (1.7%) was caused by a multi-azole resistant Aspergillus fumigatus isolate. The resistance mechanism was identified as a TR/L98H mutation in the cyp51A gene.
Discussion: The incidence rate of invasive aspergillosis was lower than expected from previous reports. This might be associated with the frequent use of antifungal prophylaxis and a reserved attitude towards invasive diagnostic measures. While invasive disease by a multi-azole resistant isolate was observed, this seems to be a rare event in clinical practice.